| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |